SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001178913-23-003298
Filing Date
2023-10-10
Accepted
2023-10-10 11:15:48
Documents
2
Group Members
SPHERA GLOBAL HEALTHCARE GP LTDSPHERA GLOBAL HEALTHCARE MANAGEMENT LP

Document Format Files

Seq Description Document Type Size
1 SC 13G zk2330364.htm SC 13G 85236
2 EXHIBIT 1 exhibit_1.htm EX-99 6273
  Complete submission text file 0001178913-23-003298.txt   93232
Mailing Address 4 ITZHAK SADE BUILDING A 29TH FLOOR TEL AVIV L3 6777520
Business Address 4 ITZHAK SADE BUILDING A 29TH FLOOR TEL AVIV L3 6777520 972-3-6845535
SPHERA FUNDS MANAGEMENT LTD. (Filed by) CIK: 0001496201 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3
Type: SC 13G

Mailing Address 2200 BRIDGE PKWY SUITE #102 REDWOOD CITY CA 94065
Business Address 2200 BRIDGE PKWY SUITE #102 REDWOOD CITY CA 94065 6505491400
Jasper Therapeutics, Inc. (Subject) CIK: 0001788028 (see all company filings)

IRS No.: 842984849 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91228 | Film No.: 231316615
SIC: 2836 Biological Products, (No Diagnostic Substances)